PMN

Latest SEC Filings & News for PMN

1 most recent filing and news item mentioning PMN. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day

curl "https://api.brieftape.com/v1/tickers/PMN/news?limit=20"

Pull PMN filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

RegulatoryJul 28, 2026Positive

PMN310 Phase 1b AD Trial Shows No ARIA-E

ProMIS Neurosciences reported positive interim safety and biomarker data for PMN310 in an Alzheimer's trial, with no ARIA-E observed. Evidence of early biomarker changes suggests potential efficacy as a tolerated alternative to standard amyloid therapies.

View filing at SEC.gov →

AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.